Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119243) titled 'Application and validation of generative artificial intelligence virtual enhanced CT in the diagnosis and treatment of pancreatic tumors: a multicenter, retrospective diagnostic trial' on Feb. 25.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai Changhai Hospital
Condition:
Pancreatic tumors
Intervention:
Gold Standard:The histopathological results of surgically resected specimens or needle biopsy are used as the final diagnosis
Recruitment Status: Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-02-25
Target Sample Size: Target co...